Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethics in Research01:56

Ethics in Research

24.0K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
24.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

182
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
182
Rab Proteins01:14

Rab Proteins

4.1K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.1K
Protein Modifications in the RER01:26

Protein Modifications in the RER

5.6K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.6K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.6K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Refractory epilepsy from lead poisoning.

BMJ neurology open·2026
Same author

Structure-Guided Optimization of Novel Inhibitors of <i>Plasmodium</i> Lysyl-tRNA Synthetase with Multistage Activity against Malaria Parasites.

Journal of medicinal chemistry·2026
Same authorSame journal

Technology Licensing & Commercialization Considerations for Clinical Scientists.

LES nouvelles. Licensing Executives Society (U.S.A.)·2026
Same authorSame journal

Accelerating Federal Technology Transfer Through a Startup Challenge Licensing Mode.

LES nouvelles. Licensing Executives Society (U.S.A.)·2026
Same author

Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.

Nature cancer·2026
Same author

The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trial.

The lancet. Gastroenterology & hepatology·2026

Related Experiment Video

Updated: Sep 18, 2025

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience
10:17

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience

Published on: November 15, 2024

1.2K

R2B Contracts: Complexities And Considerations When Contracting With Universities And Other Not-For-Profit Research

Mark Anderson1, Brian A Coblitz2, Jorge L Contreras3

  • 1Managing Partner, Anderson Law LLP, and Honorary Professor, Faculty of Laws, University College London, Oxfordshire, England UK.

LES Nouvelles. Licensing Executives Society (U.S.A.)
|June 27, 2025
PubMed
Summary

Research-practicing entities (RPEs) face challenges when contracting with commercial enterprises due to differing priorities. Understanding each party's needs can mitigate frustrations in industry collaborations.

More Related Videos

Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.0K
Use of Galvanic Skin Responses, Salivary Biomarkers, and Self-reports to Assess Undergraduate Student Performance During a Laboratory Exam Activity
07:32

Use of Galvanic Skin Responses, Salivary Biomarkers, and Self-reports to Assess Undergraduate Student Performance During a Laboratory Exam Activity

Published on: February 10, 2016

9.5K

Related Experiment Videos

Last Updated: Sep 18, 2025

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience
10:17

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience

Published on: November 15, 2024

1.2K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.0K
Use of Galvanic Skin Responses, Salivary Biomarkers, and Self-reports to Assess Undergraduate Student Performance During a Laboratory Exam Activity
07:32

Use of Galvanic Skin Responses, Salivary Biomarkers, and Self-reports to Assess Undergraduate Student Performance During a Laboratory Exam Activity

Published on: February 10, 2016

9.5K

Area of Science:

  • Scientific research and development
  • Intellectual property management
  • Inter-organizational collaboration

Background:

  • Research-practicing entities (RPEs) engage in increasing collaborations with commercial enterprises for research funding and intellectual property licensing.
  • RPEs prioritize knowledge generation, dissemination, and public interest, often guided by legal and funding mandates.
  • Commercial enterprises have different priorities focused on private interests, leading to potential conflicts.

Purpose of the Study:

  • To describe the legal and cultural features and constraints RPEs encounter when contracting with industry.
  • To highlight the mismatch in priorities and decision-making processes between RPEs and commercial entities.
  • To provide insights for mitigating frustrations in industry-RPE collaborations.

Main Methods:

  • Analysis of legal and cultural factors influencing RPE-industry contracts.
  • Examination of stakeholder involvement in RPEs' contracting decisions.
  • Review of potential sources of conflict and strategies for mitigation.

Main Results:

  • RPEs' primary mission to generate and disseminate knowledge, and their obligation to act in the public interest, can conflict with industry's private interests.
  • The involvement of multiple internal stakeholders within RPEs adds complexity to decision-making processes.
  • Differences in priorities and decision-making lead to frustrations during contract negotiation and performance.

Conclusions:

  • Understanding the distinct priorities and needs of both RPEs and industry is crucial for successful collaborations.
  • Proactive communication and a clear understanding of each party's constraints can mitigate contractual challenges.
  • Successful industry-RPE partnerships require navigating legal and cultural differences to align mutual interests.